Fig. 2From: Myeloid-specific TAK1 deletion results in reduced brain monocyte infiltration and improved outcomes after strokeIncrease in splenic monocytes and decrease in CD3+ T and CD19+ B cells in TAK1ΔM mice. a Frequency of live cells in sham and MCAo groups. b Increase in splenic monocytes. c Increase splenic neutrophils after deletion of TAK1 from myeloid cells. d Decline in splenic CD3+ T cells and e CD19+ B cells in TAK1ΔM mice. Data is presented as mean ± SEM, n = 3–5; *p < 0.05, **p < 0.01 (two-way ANOVA followed by post-hoc Tukey)Back to article page